- Home
- SFWL vs PMVP Comparison
SFWL vs PMVP Comparison
Compare SFWL & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SFWL
- PMVP
- Stock Information
- Founded
- SFWL 2001
- PMVP 2013
- Country
- SFWL China
- PMVP United States
- Employees
- SFWL N/A
- PMVP N/A
- Industry
- SFWL Trucking Freight/Courier Services
- PMVP Medicinal Chemicals and Botanical Products
- Sector
- SFWL Industrials
- PMVP Health Care
- Exchange
- SFWL Nasdaq
- PMVP Nasdaq
- Market Cap
- SFWL 82.3M
- PMVP 77.4M
- IPO Year
- SFWL 2023
- PMVP 2020
- Fundamental
- Price
- SFWL $1.15
- PMVP $1.23
- Analyst Decision
- SFWL
- PMVP Strong Buy
- Analyst Count
- SFWL 0
- PMVP 1
- Target Price
- SFWL N/A
- PMVP $5.00
- AVG Volume (30 Days)
- SFWL 24.3K
- PMVP 2.5M
- Earning Date
- SFWL 08-27-2025
- PMVP 11-06-2025
- Dividend Yield
- SFWL N/A
- PMVP N/A
- EPS Growth
- SFWL 31.68
- PMVP N/A
- EPS
- SFWL 0.14
- PMVP N/A
- Revenue
- SFWL $540,461,000.00
- PMVP N/A
- Revenue This Year
- SFWL N/A
- PMVP N/A
- Revenue Next Year
- SFWL N/A
- PMVP N/A
- P/E Ratio
- SFWL $8.11
- PMVP N/A
- Revenue Growth
- SFWL 21.10
- PMVP N/A
- 52 Week Low
- SFWL $0.86
- PMVP $0.81
- 52 Week High
- SFWL $1.60
- PMVP $1.84
- Technical
- Relative Strength Index (RSI)
- SFWL 57.68
- PMVP 39.98
- Support Level
- SFWL $1.10
- PMVP $1.19
- Resistance Level
- SFWL $1.18
- PMVP $1.84
- Average True Range (ATR)
- SFWL 0.09
- PMVP 0.16
- MACD
- SFWL 0.01
- PMVP -0.03
- Stochastic Oscillator
- SFWL 51.72
- PMVP 6.15
About SFWL Shengfeng Development Limited
Shengfeng Development Ltd is a holding company. Through its subsidiaries, it offers contract logistics services in China. The contract logistics services offered by the company include planning and designing supply chains, designing facilities, processing orders, collecting payments, managing inventories, and providing client services.
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.